bioAffinity Technologies, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
bioAffinity Technologies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2025.
  • bioAffinity Technologies, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was -$1.52M, a 8787% decline year-over-year.
  • bioAffinity Technologies, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was -$1.59M, a 2919% decline year-over-year.
  • bioAffinity Technologies, Inc. annual Nonoperating Income (Expense) for 2024 was -$74.7K, a 231% decline from 2023.
  • bioAffinity Technologies, Inc. annual Nonoperating Income (Expense) for 2023 was $57.2K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$1.59M -$1.52M -$1.5M -8787% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$86.4K -$24.6K -$11.7K -90.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 -$74.7K -$20.3K +$8.12K +28.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$82.9K -$24.4K -$30.3K -513% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$52.5K -$17.1K -$59.8K -140% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $7.3K -$12.9K -$49.9K -135% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $57.2K -$28.5K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $5.91K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $42.8K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $37K +$1.18M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$1.15M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.